|Articles|April 1, 2019
- Applied Clinical Trials-04-01-2019
- Volume 28
- Issue 4
Applied Clinical Trials, April 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Global Standardization of Clinical Research Dataalmost 7 years ago
FDA Seeks to Broaden Clinical Trial Eligibility Criteriaalmost 7 years ago
The Framework for FDA’s Real-World Evidence Programalmost 7 years ago
Challenges in Conveying Translational Research Messagealmost 7 years ago
Emerging Biopharma Deserve TLC from CROsalmost 7 years ago
Non-Data Scientists: The Evolving Role of Clinical Data Managementalmost 7 years ago
Optimizing Study Design in Real-World Evidence Generationalmost 7 years ago
Regenerative Medicine Companies Successfully Advance Stem Cell TherapiesNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: De-Identified RWE Gains Ground, HHS Funding Stabilizes Research, and US Finalizes WHO Exit
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
4
ACT Brief: De-Identified Data Expands Trial Design, Global Production Normalizes, and FDA Updates Quality Framework
5